Titel

Merkliste
1 Ergebnisse

table2_Pharmacoeconomic Evaluation of Cancer Biosimilars Wo..:

Hui-Yao Huang (5113442) ; Cheng-Cheng Liu (1895824) ; Yue Yu (260119)...
https://figshare.com/articles/dataset/table2_Pharmacoeconomic_Evaluation_of_Cancer_Biosimilars_Worldwide_A_Systematic_Review_docx/13603583. , 2021

Link: https://doi.org/10.3389/fphar.2020.572569.s002

RT Journal
T1 <Title>table2_Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic Review.docx</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_13603583&Exemplar=1&LAN=DE
				
A1 Hui-Yao Huang (5113442)
A1 Cheng-Cheng Liu (1895824)
A1 Yue Yu (260119)
A1 Le Wang (165105)
A1 Da-Wei Wu (3351836)
A1 Lan-Wei Guo (5113418)
A1 Shu-Hang Wang (9632759)
A1 Hong Fang (43040)
A1 Ying Bai (107853)
A1 Yuan Fang (132924)
A1 Qi Fan (160566)
A1 Chao Sun (139686)
A1 Ying Wu (19057)
A1 Ju-Fang Shi (5113412)
A1 Fei Ma (113764)
A1 Yu Tang (343157)
A1 Min Dai (219435)
A1 Ning Li (45258)
YR 2021
K1 Pharmacology
K1 Basic Pharmacology
K1 Clinical Pharmacology and Therapeutics
K1 Clinical Pharmacy and Pharmacy Practice
K1 Pharmaceutical Sciences
K1 Pharmacogenomics
K1 Toxicology (incl. Clinical Toxicology)
K1 Pharmacology and Pharmaceutical Sciences not elsewhere classified
K1 cancer
K1 biosimilars
K1 pharmacoeconomic evaluation
K1 cost minimization analysis
K1 budget impact analysis
K1 systematic review
JF https://figshare.com/articles/dataset/table2_Pharmacoeconomic_Evaluation_of_Cancer_Biosimilars_Worldwide_A_Systematic_Review_docx/13603583
LK http://dx.doi.org/https://doi.org/10.3389/fphar.2020.572569.s002
DO https://doi.org/10.3389/fphar.2020.572569.s002
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)